Pentoxyphylline and propentophylline are inhibitors of TNF-α release in monocytes activated by advanced glycation endproducts

Journal of Neural Transmission

Volumn 111, Issue 3, 2004, Pages 441-447

  Meiners, I ^a   Hauschildt, S ^a   Nieber, K ^a   Munch G ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Advanced glycation endproducts; Alzheimer's disease; Tumor necrosis factor; Xanthine

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CAFFEINE; GLUCOSE; OVALBUMIN; PENTOXIFYLLINE; PROPENTOFYLLINE; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA; XANTHINE DERIVATIVE;

ADULT; ALZHEIMER DISEASE; ARTICLE; CELL ACTIVATION; CHICKEN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ALBUMINS; ANIMALS; CELLS, CULTURED; CHICKENS; DOSE-RESPONSE RELATIONSHIP, DRUG; EGGS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MONOCYTES; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA; XANTHINES;

EID: 1542313770     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-003-0066-y     Document Type: Article

References (19)

1. Bamberger ME, Landreth GE (2002) Inflammation, apoptosis, and Alzheimer's disease. Neuroscientist 8: 276-283
2. Bengis-Garber C, Gruener N (1996) Protein kinase A downregulates the phosphorylation of p47 phox in human neutrophils: a possible pathway for inhibition of the respiratory burst. Cell Signal 8: 291-296
3. Blasko I, Grubeck-Loebenstein B (2003) Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease. Drugs Aging 20: 101-113
4. Bodor J, Habener JF (1998) Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytes. J Biol Chem 273: 9544-9551
5. Bouma MG, Stad RK, van den Wildenberg FA, Buurman WA (1994) Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 153: 4159-4168
6. Broussas M, Cornillet-Lefebvre P, Potron G, Nguyen P (1999) Inhibition of fMLP-triggered respiratory burst of human monocytes by adenosine: involvement of A3 adenosine receptor. J Leukoc Biol 66: 495-501
7. Chen M, Yang Z, Wu R, Nadler JL (2002) Lisofylline, a novel antiinflammatory agent, protects pancreatic beta-cells from proinflammatory cytokine damage by promoting mitochondrial metabolism. Endocrinology 143: 2341-2348
8. Katsuse O, Iseki E, Kosaka K (2003) Immunohistochemical study of the expression of cytokines and nitric oxide synthases in brains of patients with dementia with Lewy bodies. Neuropathology 23: 9-15
9. Kittner B, Rossner M, Rother M (1997) Clinical trials in dementia with propentophylline. Ann NY Acad Sci 826: 307-316
10. Marcusson J, Rother M, Kittner B, Rossner M, Smith RJ, Babic T, Folnegovic-Smalc V, Moller HJ, Labs KH (1997) A 12-month, randomized, placebo-controlled trial of propentophylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentophylline Study Group. Dement Geriatr Cogn Disord 8: 320-328
11. Möller HJ (1998) Therapeutic strategies based on immunological hypotheses of Alzheimer's disease. J Neural Transm [Suppl] 54: 175-186
12. Moore AH, O'Banion MK (2002) Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease. Adv Drug Deliv Rev 54: 1627-1656
13. Neumann A, Schinzel R, Palm D, Riederer P, Munch G (1999) High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression. FEBS Lett 453: 283-287
14. Perl A, Gergely P Jr, Puskas F, Banki K (2002) Metabolic switches of T-cell activation and apoptosis. Antioxid Redox Signal 4: 427-443
15. Schubert P, Ogata T, Rudolphi K, Marchini C, McRae A, Ferroni S (1997) Support of homeostatic glial cell signaling: a novel therapeutic approach by propentophylline. Ann NY Acad Sci 826: 337-347
16. Schubert P, Ogata T, Miyazaki H, Marchini C, Ferroni S, Rudolphi K (1998) Pathological immuno-reactions of glial cells in Alzheimer's disease and possible sites of interference. J Neural Transm [Suppl] 54: 167-174
17. Schubert P, Morino T, Miyazaki H, Ogata T, Nakamura Y, Marchini C, Ferroni S (2000) Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. Ann NY Acad Sci 903: 24-33
18. Wang P, Wu P, Ohleth KM, Egan RW, Billah MM (1999) Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils. Mol Pharmacol 56: 170-174
19. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL (2001) Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280: E685-E694